Artelon® Product Line Under New Ownership, Relocates Operations from Sweden to U.S. (press release)
International Life Sciences, LLC (dba, Artelon®) acquired the assets of Artimplant® AB in January 2014 and has relocated operations from Sweden to the United States. This international relocation allows Artelon® to more closely engage its largest customer base and provide additional opportunities for product development that were not previously available.
Adam Barese now serves as the Chief Executive Officer of the Organization. After garnering almost two decades of medical industry experience...